NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Sleep disease link to cancer
Mon May 21st - There may be a link between sleep disorder and cancer, researchers have reported. More
Glow hope for medicine
Mon May 21st - Scientists have taken a further step towards bringing tiny glowing crystals, known as quantum dots, into medicine, it has been revealed. More
Heart drugs may prevent cancer
Mon May 21st - Statins were developed to reduce cholesterol and found to have a range of other benefits for heart patients - and new findings suggest this may include preventing cancer. More
RECENT COMMENTS
On 21/05/2012 Editor wrote:
Useful link from the ESC for people concerned abou - Read more

On 11/05/2012 Anonymous wrote:
In fact the biggest risk is the patch and the ring - Read more

On 10/05/2012 Editor wrote:
Welcome to Englemed comments. We'd like your view - Read more

THIS WEEK'S STORIES
Day-time abstention may help combat obesity
Fri May 18th - Regular eating times and fasting for a number of hours a day might prove to be beneficial to our health, a US study has claimed. More
Conflict over diet advice for pregnant women
Fri May 18th - Pregnant women can reduce the risk of developing serious complications by following a calorie controlled diet, researchers say today. More
Athlete pain tolerance could aid treatment
Fri May 18th - Athletes’ ability to tolerate pain for longer than non-athletes could give pain management specialists new ways of treating patients, researchers reported yesterday. More
New heart medicine drive
Thurs May 17th - People with high cholesterol are being encouraged to take their medicines today as research highlighted the benefits of the medicines. More
Nine new breast cancer genes
Thurs May 17th - Nine new genes have been found linked to breast cancer, British scientists revealed last night. More
ENGLEMED HEALTH NEWS

Body-clock gene link to diabetes

Monday January 30th, 2012

British researchers have linked the development of diabetes late in life with genetic mutations in the body-clock.

The finding, reported last night, may give new insights into the relationship between sleeping habits and the development of diabetes.

Reported in Nature Genetics, it is the second time researchers at Imperial College, London, have linked diabetes to the body-clock hormone melatonin.

But it is the first time they have found a connection between rare mutations and a much increased risk of type 2 diabetes. Their earlier work showed a link between common variations in a melatonin gene and a small increase risk of diabetes.

The new research finds a six times increase from four rare mutations.

According to researcher Professor Philippe Froguel, the most likely explanation is that melatonin normally controls the body's release of insulin - and that the mutations mean this does not happen properly.

The findings come from a study of some 7,632 people in Britain and France.

The scientists studied a gene called MT2, which is meant to respond to melatonin levels.

Professor Froguel said: "Although each mutation is rare, they are common in the sense that everyone has a lot of very rare mutations in their DNA. Cataloguing these mutations will enable us to much more accurately assess a person’s risk of disease based on their genetics."

Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. A. Bonnefond et al. Nature Genetics. January 29 2012.

Tags: Diabetes | Genetics | UK News

Printer friendly page Printer friendly page

CATEGORIES